Citation: Sd. Reed et al., Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals, STROKE, 32(8), 2001, pp. 1832-1839
Authors:
Barreto, AM
Schwartz, GG
Woodruff, R
Cramer, SC
Citation: Am. Barreto et al., 25-hydroxyvitamin D-3, the prohormone of 1,25-dihydroxyvitamin D-3, inhibits the proliferation of primary prostatic epithelial cells, CANC EPID B, 9(3), 2000, pp. 265-270
Authors:
Feinklestein, SP
Fisher, M
Furland, AJ
Goldstein, LB
Gorelick, PB
Kaste, M
Lees, KR
Traystman, RJ
Albers, GW
Anwer, UE
Ashwood, T
Barone, FC
Basta, SL
Bogousslavsky, J
Buchan, AM
Cady, WJ
Chan, PH
Clemens, JA
Cox, BF
Craddock, RE
Cramer, SC
del Zoppo, GJ
Dielrich, WD
Elliott, P
Faden, AI
Feuerstein, GZ
Ginsberg, MD
Gold, M
Greene, WL
Hall, ED
Hsu, CY
Hunter, AJ
Lai, M
Lesko, LM
Levy, DE
Li, FH
Locke, KW
Lodge, D
Lowe, D
Marcoux, FW
McCulloch, J
McDermott, J
Meibach, R
Messersmith, EK
Moseley, M
Moskowitz, MA
Mueller, AL
Munro, F
Nudo, RJ
Oeda, J
Ohlstein, EH
Parsons, A
Patmore, L
Poole, RM
Pschorn, U
Pulsinelli, WA
Sacco, RL
Saeki, S
Salazar-Grueso, E
Sandage, BW
Schallert, T
Schielke, GP
Sharkey, J
Sotak, CH
Steiger, B
Storall, S
Takahashi, Y
Tumas, D
Van Bruggen, N
Versavel, M
Vornov, J
Walker, MD
Wallin, B
Wang, J
Warach, S
Wells, DS
Witcher, JA
Citation: Sp. Feinklestein et al., Recommendations for standards regarding preclinical neuroprotective and restorative drug development, STROKE, 30(12), 1999, pp. 2752-2758
Citation: Sc. Cramer et al., Activation of distinct motor cortex regions during ipsilateral and contralateral finger movements, J NEUROPHYS, 81(1), 1999, pp. 383-387